New Delhi: The Drug Controller General of India (DCGI), Rajeev Raghuvanshi, has directed state authorities to withdraw AstraZeneca’s Olaparib Tablets, 100mg and 150mg, due to potential adverse ...
Meindert Boysen, director of the NICE Centre for Health Technology Evaluation, said: “The availability of olaparib tablets as maintenance therapy is an important development in the management of ...
Olaparib for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapy
The list price of olaparib is £2,317.50 per 56 pack of 150-mg tablets (excluding VAT, BNF online, accessed October 2024). The company has a confidential commercial access agreement with NHS England.
Hosted on MSN7mon
FDA: 15 essential drugs VAT-exemptIncluded in the list are medicines for cancer, namely Avelumab 200 milligram/10 milliliter (20 mg/mL concentrate solution for infusion), Acalabrutinib 100 mg capsule, Olaparib 100 mg tablet ...
Olaparib for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapy
Olaparib is recommended, within its marketing authorisation, as an option for treating HER2-negative locally advanced or metastatic breast cancer with germline BRCA1 or BRCA2 mutations in adults who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback